Essentia Biosciences

Essentia Biosciences is a biopharmaceutical company specializing in iPSC-derived cell drug therapies, with a focus on the research and industrialization of islet drugs as well as the development of a universal iPSC platform. Essentia Biosciences has established research laboratories in Daxing, Beijing, China, and Oxford, UK, striving to become a leading Chinese enterprise in international multicenter clinical trials for cell drugs and a pioneer in bridging the iPSC industries between China and the rest of the world.